The largest database of trusted experimental protocols

C 12500

Manufactured by PromoCell
Sourced in Germany

The C-12500 is a laboratory equipment piece designed for general-purpose applications. It features a compact and durable construction. The core function of the C-12500 is to provide a reliable and consistent performance for various laboratory tasks.

Automatically generated - may contain errors

2 protocols using c 12500

1

Vascular cell adhesion on PCL films

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human umbilical vein endothelial cells (HUVECs; C-12200 PromoCell GmbH, Heidelberg, DEU) and primary human umbilical artery smooth muscle cells (HUASMCs; C-12500 PromoCell GmbH, Heidelberg, DEU), were used to assess vascular cell adhesion onto the PCL film samples. HUVECs were cultured in endothelial cell growth medium (C-22011 PromoCell GmbH, Heidelberg, DEU ) supplemented with 1% (v/v) penicillin-streptomycin, 2% (v/v) fetal bovine serum, 0.4% (v/v) endothelial cell growth supplement, 0.1 ng/ml EGF, 1 ng/ml bFGF, 90 μg/ml heparin, and 1 μg/ml hydrocortisone. HUASMCs were cultured in smooth muscle cell growth medium (C-22062 PromoCell GmbH, Heidelberg, DEU) supplemented with 1% (v/v) antibiotic-antimycotic, 5% (v/v) fetal bovine serum, 0.5 ng/ml EGF, 2 ng/ml bFGF, and 5 μg/ml insulin. All cells were incubated at 37 °C, 5% CO2 and grown to 80% confluency before use with experiments. Only passages between 3 and 6 were used for both cell lines.
+ Open protocol
+ Expand
2

Culturing Endothelial, Smooth Muscle, and Pericyte Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Studies were performed using pooled primary human umbilical vein endothelial cells (HUVEC, C-12203), human umbilical artery smooth muscle cells (HUASMC, C-12500) and human pericytes from placenta (HPC, hPC-PL, C-12980) purchased from PromoCell (Heidelberg, Germany). Cells were grown in the corresponding media from PromoCell (Heidelberg, Germany): Endothelial Cell Growth Medium 2 (Ready-to-use, C-22011), Smooth Muscle Cell Growth Medium 2 (Ready-to-use, C-22062) and Pericyte Growth Medium (Ready-to-use, C-28040) with addition of 1% penicillin/streptomycin (Gibco). Cells were routinely cultured under nitrogen atmosphere (7% O2, 5% CO2) and passaged twice a week for a maximum of 15 passages using trypsin (Gibco). BPDE was purchased from BIU Biochemical Institute for Environmental Carcinogens, Prof. Dr. G. Grimmer-Stiftung (Grosshansdorf, Germany). BPDE was dissolved in water-free THF/5% trimethylamine (1 mM) and stored at −80 °C. To avoid hydrolysis of the epoxides, dilutions from the stock solution were always prepared fresh immediately before incubation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!